With this prestigious recognition, EMBO honors Christoph Bock for his scientific contributions at the interface of biotechnology, bioinformatics, and molecular medicine. His research combines experimental immunology and cancer biology with computational methods, including machine learning and artificial intelligence. “We develop technologies to help understand human diseases in all their complexity, and we aim to program immune cells as molecular therapies,” Christoph Bock says, describing the main focus of his work.